+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary Pharmaceuticals Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery

  • ID: 5414911
  • Report
  • August 2021
  • Region: Global
  • 397 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Merck & Co., Inc.
  • Zoetis Inc.

This report provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for veterinary pharmaceuticals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global veterinary pharmaceuticals market opportunities and strategies to 2030 report from the publisher answers all these questions and many more.

The report covers the following chapters:

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - This section gives the segmentation of the veterinary pharmaceuticals market by geography, by type of product, by animal type, by route of administration and by end use channel.
  • Market Characteristics - The market characteristics section of the report defines and explains the veterinary pharmaceuticals market. This chapter includes different products covered in the report and basic definitions.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the veterinary pharmaceuticals industry supply chain.
  • Product Analysis - The product analysis section of the report describes the leading products along with key features and differentiators for those products/services.
  • Customer Information - This chapters covers recent customer and service providers’ trends/preferences in the global veterinary pharmaceuticals market.
  • Trends and Strategies - This chapter describes the major trends shaping the global veterinary pharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Regulatory Landscape - The section briefs on the regulatory landscape of veterinary pharmaceuticals.
  • Impact of COVID-19 - The section briefs on the impact of COVID-19 on the veterinary pharmaceuticals market.
  • Global Market Size and Growth - This section contains the global historic (2015-2020) and forecast (2020-2025, 2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast period.
  • Segmentation - This section contains the market values (2015-2025, 2030F) and analysis for different segments in the market.
  • Global Macro Comparison - The global veterinary pharmaceuticals market comparison with macro-economic factors gives the veterinary pharmaceuticals market size, percentage of GDP, and average veterinary pharmaceuticals market expenditure.
  • Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025, 2030F) market value and growth, and market share comparison by region.
  • Regional Market Size and Growth - This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025, 2030F) market value, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa), and five countries (China, India, Japan, the USA and the UK).
  • Competitive Landscape - This section covers details on the competitive landscape of the global veterinary pharmaceuticals market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background - This section describes the animal medicine market of which the veterinary pharmaceuticals market is a segment. This chapter includes the animal medicine market 2015-2025, 2030F values, and regional analyses for the animal medicine market.
  • Opportunities and Strategies - This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions and Recommendations - This section includes conclusions and recommendations based on the findings of the research.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

1) By Type of Pharmaceutical: Veterinary Parasiticides; Veterinary Vaccines; Veterinary Antibiotics; Other Veterinary Pharmaceuticals
2) By Animal Type: Livestock; Companion Animal
3) By Route of Administration: Oral; Others
4) By End Use Channel: Veterinary Hospitals; Pharmacies and Drug stores; Veterinary Clinics
5) By Type of Antibiotic: Tetracyclines; Penicillin; Macrolides; Sulphanomides; Aminoglycosides; Others
6) By Type of Vaccine: Live Attenuated Vaccines; Inactivated Vaccines; Recombinant Vaccines; Others

Companies Mentioned:

Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co., Inc.; Elanco Animal Health Incorporated; Ceva Santé Animale

Countries:

China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions:

Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series:

Five years historic and ten years forecast.

Data Segmentations:

Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:

Data and analysis throughout the report is sourced using end notes.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Merck & Co., Inc.
  • Zoetis Inc.
1. Veterinary Pharmaceuticals Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Type Of Pharmaceuticals
6.3. Segmentation By Animal Type
6.4. Segmentation By Route Of Administration
6.5. Segmentation By End Use Channel
6.6. Segmentation By Type Of Vaccines
6.7. Segmentation By Type Of Antibiotics

7. Veterinary Pharmaceuticals Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Type Of Product
7.2.1. Veterinary Vaccines
7.2.2. Veterinary Antibiotics
7.2.3. Veterinary Parasiticides
7.2.4. Other Veterinary Pharmaceuticals
7.3. Market Segmentation By End Use Channel
7.3.1. Veterinary Hospitals
7.3.2. Veterinary Clinics
7.3.3. Pharmacies Drug Stores
7.4. Market Segmentation By Route Of Administration
7.4.1. Oral
7.4.2. Others
7.5. Market Segmentation By Type Of Animal
7.5.1. Livestock
7.5.2. Companion Animals
7.6. Market Segmentation By Type Of Vaccine
7.6.1. Inactivated Vaccines
7.6.2. Attenuated Vaccines
7.6.3. Recombinant Vaccines
7.6.4. Others
7.7. Market Segmentation By Type Of Antibiotics
7.7.1. Tetracyclines
7.7.2. Penicillin
7.7.3. Sulphonamides
7.7.4. Macrolides
7.7.5. Aminoglycosides
7.7.6. Others

8. Veterinary Pharmaceuticals Market, Supply Chain Analysis
8.1. Raw Material Suppliers
8.2. Contract Research Organization (CRO)
8.3. Veterinary Pharmaceutical Manufacturer
8.3.1. Drug Discovery
8.3.2. Preclinical Clinical Trials
8.3.3. Patents Upon Discovery Approval
8.3.4. Drug Manufacturing
8.4. Contract Manufacturing Organization (CMO)
8.5. Wholesalers/Distributors
8.6. Retailers (Pharmacies Veterinary Shops) Veterinary Clinics
8.7. Veterinarians
8.8. End-Users

9. Veterinary Pharmaceuticals Market, Product/Service Analysis -Product/Service Examples

10. Veterinary Pharmaceuticals Market Customer Information
10.1. Delay In Veterinary Care Due To COVID-19
10.2. Impact Of COVID-19 On Veterinary Hospitals
10.3. Veterinary Telemedicine For Chronic Disease Management
10.4. Impact Of Parasites On Pets Health
10.5. Decrease In Veterinary Clinical Activities
10.6. Millennials Would Put Pet's Health Before Their Own
10.7. Dog Cat Owners Alike Are Concerned About The Cost Of Medical Treatments For Their Pets
10.8. Lack Of Awareness Among Food Animal Producers About The Proper Use Of Antibiotics
10.9. Opioids Shortages Compel Veterinarians To Use Less Effective Drugs As Therapeutic Choices
10.10. US Veterinarians Are Reluctant To Discuss The Therapeutic Use Of Marijuana In Dogs
10.11. Pet Ownership In The USA Has Tripled Over The Past Few Years
10.12. Pet Insurance Penetration In The USA Is Very Low
10.13. Cat Dog Medications Are Still Sold Mainly In Veterinary Clinics
10.14. Pet Obesity Remains A Big Issue
10.15. The More Pet Owners Learn About Scientific Research On The Benefits Of The Human-Animal Bond, The More Likely They Are To Take Actions To Improve Pet Health.

11. Veterinary Pharmaceuticals Market Trends Strategies
11.1. Strategic Collaborations Partnerships To Drive Innovations
11.2. Development Of Chewable Tablets
11.3. Production Of Generic Drugs For Animal Care
11.4. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
11.5. Oral Drug Solutions For The Treatment Of Feline Hypertension
11.6. Use of Subunit Virus-Like Particle (VLP)-Based Vaccines
11.7. Use Of Immunotherapy
11.8. Super-Combo Parasiticides
11.9. Development Of Vaccines
11.10. New Treatments For Arthritis
11.11. Use Of Next Generation Sequencing (NGS)

12. Global Veterinary Pharmaceuticals Market Regulatory Landscape
12.1. Need For Separate Regulation For The Veterinary Pharmaceuticals Industry
12.2. Current Regulatory Scenario
12.2.1. USA
12.2.2. Europe
12.2.3. India
12.2.4. Brazil
12.2.5. Australia and New Zealand
12.2.6. Africa
12.3. Regional Disparities In Regulations
12.3.1. Lack Of Regulatory Guidance
12.3.2. Variations In Veterinary Pharmaceuticals Development Processes
12.3.3. Variations In Safety Considerations For Veterinary Pharmaceuticals
12.3.4. Differences In Registration Procedures
12.4. Global Regulation Harmonization Initiatives
12.5. Recent Updates On Veterinary Pharmaceutical Regulations

13. COVID-19 Impact On The Veterinary Pharmaceuticals Market
13.1. Supply Side Factors
13.1.1. Impact On Leading Global Veterinary Pharmaceuticals Companies
13.1.2. Decline In The Launch Of New Products
13.1.3. Safety Measures Being Followed By Veterinary Pharmaceuticals Manufacturers
13.1.4. Revocation Of Events, Conferences Expos
13.2. Demand Side Factors
13.2.1. Stockpiling Of Veterinary Pharmaceuticals (Panic Purchasing)
13.2.2. Online Purchasing Of Veterinary Pharmaceuticals
13.2.3. Increase In Pet Ownership Adoptions
13.2.4. Only Emergency Services Being Offered By Veterinarians
13.3. Regulatory Interventions
13.4. Future Outlook

14. Global Veterinary Pharmaceuticals Market Size Growth
14.1. Market Size
14.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
14.2.1. Drivers Of The Market 2015 - 2020
14.2.2. Emerging Markets Growth
14.2.3. Increased Pet Spending
14.2.4. Increased Disease Prevalence
14.2.5. Restraints On The Market 2015 - 2020
14.2.6. Shortages Of Veterinarians
14.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
14.3.1. Drivers Of The Market 2020 - 2025
14.3.2. Increasing Penetration Of Pet Insurance
14.3.3. Restraints On The Market 2020 - 2025

15. Global Veterinary Pharmaceuticals Market Segmentation
15.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.1.1. Veterinary Parasiticides
15.1.2. Veterinary Vaccines
15.1.3. Others-Veterinary Pharmaceuticals
15.1.4. Veterinary Antibiotics
15.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.2.1. Livestock
15.2.2. Companion Animal
15.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.3.1. Oral
15.4. Global Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.4.1. Veterinary Hospitals
15.4.2. Pharmacies Drug stores
15.4.3. Veterinary Clinics

16. Global Veterinary Pharmaceuticals Market Sub-Segmentation
16.1. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
16.1.1. Live Attenuated Vaccines
16.1.2. Inactivated Vaccines
16.1.3. Recombinant Vaccines
16.1.4. Others
16.2. Global Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
16.2.1. Others
16.2.2. Tetracyclines
16.2.3. Penicillins
16.2.4. Macrolodes
16.2.5. Sulphonamides
16.2.6. Aminoglycosides

17. Veterinary Pharmaceuticals Market, Regional Country Analysis
17.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
17.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)

18. Asia-Pacific Veterinary Pharmaceuticals Market
18.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. COVID-19 Impact
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory Bodies
18.1.8. Major Associations
18.1.9. Tax Levied
18.1.10. Corporate Tax Structure
18.1.11. Investments
18.1.12. Major Companies
18.2. Asia-Pacific Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.3. Asia-Pacific Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.6. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.7. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.8. Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
18.9. Australia Veterinary Pharmaceuticals Market
18.10. Australia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.11. Australia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.12. Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.13. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.14. Australia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.15. Australia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.16. China Veterinary Pharmaceuticals Market
18.17. China Veterinary Pharmaceuticals Market Overview
18.17.1. Country Information
18.17.2. Market Information
18.17.3. COVID-19 Impact
18.17.4. Background Information
18.17.5. Government Initiatives
18.17.6. Regulations
18.17.7. Regulatory Bodies
18.17.8. Corporate Tax Structure
18.17.9. Associations
18.17.10. Tax Levied
18.17.11. Investments
18.17.12. Major Companies
18.18. China Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.19. China Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.20. China Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.21. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.22. China Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.23. China Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.24. Indonesia Veterinary Pharmaceuticals Market
18.25. Indonesia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.26. Indonesia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.27. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.28. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.29. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.30. Indonesia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.31. India Veterinary Pharmaceuticals Market
18.32. India Veterinary Pharmaceuticals Market Overview
18.32.1. Country Information
18.32.2. Market Information
18.32.3. COVID-19 Impact
18.32.4. Background Information
18.32.5. Government Initiatives
18.32.6. Regulations
18.32.7. Regulatory Bodies
18.32.8. Major Associations
18.32.9. Tax Levied
18.32.10. Corporate Tax Structure
18.32.11. Investments
18.32.12. Major Companies
18.33. India Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.34. India Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.35. India Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.36. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.37. India Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.38. India Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.39. Japan Veterinary Pharmaceuticals Market
18.40. Japan Veterinary Pharmaceuticals Market Overview
18.40.1. Country Information
18.40.2. Market Information
18.40.3. COVID-19 Impact
18.40.4. Background Information
18.40.5. Regulations
18.40.6. Regulatory Bodies
18.40.7. Major Associations
18.40.8. Tax Levied
18.40.9. Corporate Tax Structure
18.40.10. Investments
18.40.11. Major Companies
18.41. Japan Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.42. Japan Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.43. Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.44. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.45. Japan Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.46. Japan Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.47. South Korea Veterinary Pharmaceuticals Market
18.48. South Korea Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.49. South Korea Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.50. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.51. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.52. South Korea Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.53. South Korea Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Western Europe Veterinary Pharmaceuticals Market
19.1. Western Europe Veterinary Pharmaceuticals Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. COVID-19 Impact
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Western Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
19.3. Western Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
19.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.6. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.7. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.8. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
19.9. France Veterinary Pharmaceuticals Market
19.10. France Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
19.11. France Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
19.12. France Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.13. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.14. France Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.15. France Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.16. Germany Veterinary Pharmaceuticals Market
19.17. Germany Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
19.18. Germany Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
19.19. Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.20. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.21. Germany Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.22. Germany Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.23. UK Veterinary Pharmaceuticals Market
19.24. UK Veterinary Pharmaceuticals Market Overview
19.24.1. Country Information
19.24.2. Market Information
19.24.3. COVID-19 Impact
19.24.4. Background Information
19.24.5. Government Initiatives
19.24.6. Regulations
19.24.7. Regulatory Bodies
19.24.8. Major Associations
19.24.9. Corporate Tax Structure
19.24.10. Investments
19.24.11. Major Companies
19.25. UK Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
19.26. UK Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
19.27. UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.28. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.29. UK Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.30. UK Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Eastern Europe Veterinary Pharmaceuticals Market
20.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
20.1.1. Region Information
20.1.2. Market Information
20.1.3. COVID-19 Impact
20.1.4. Background Information
20.1.5. Government Initiatives
20.1.6. Regulations
20.1.7. Regulatory Bodies
20.1.8. Major Associations
20.1.9. Tax Levied
20.1.10. Corporate Tax Structure
20.1.11. Investments
20.1.12. Major Companies
20.2. Eastern Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.3. Eastern Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
20.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.6. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.7. Eastern Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.8. Russia Veterinary Pharmaceuticals Market
20.9. Russia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
20.10. Russia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
20.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.12. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.13. Russia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.14. Russia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

21. North America Veterinary Pharmaceuticals Market
21.1. North America Veterinary Pharmaceuticals Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. COVID-19 Impact
21.1.4. Background Information
21.1.5. Government Initiatives
21.1.6. Regulations
21.1.7. Regulatory Bodies
21.1.8. Major Associations
21.1.9. Tax Levied
21.1.10. Corporate Tax Structure
21.1.11. Major Investments
21.1.12. Major Companies
21.2. North America Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.3. North America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
21.4. North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.5. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.6. North America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.7. North America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.8. USA Veterinary Pharmaceuticals Market
21.9. USA Veterinary Pharmaceuticals Market Overview
21.9.1. Country Information
21.9.2. Market Information
21.9.3. COVID-19 Impact
21.9.4. Background Information
21.9.5. Government Initiatives
21.9.6. Regulatory Bodies
21.9.7. Regulations
21.9.8. Major Associations
21.9.9. Tax Levied
21.9.10. Corporate Tax Structure
21.9.11. Major Investments
21.9.12. Major Companies
21.10. USA Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
21.11. USA Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
21.12. USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.13. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.14. USA Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
21.15. USA Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

22. South America Veterinary Pharmaceuticals Market
22.1. South America Veterinary Pharmaceuticals Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. COVID-19 Impact
22.1.4. Background Information
22.1.5. Government Initiatives
22.1.6. Regulations
22.1.7. Regulatory Bodies
22.1.8. Major Associations
22.1.9. Tax Levied
22.1.10. Corporate Tax Structure
22.1.11. Major Investments
22.1.12. Major Companies
22.2. South America Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.3. South America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.4. South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.5. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.6. South America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.7. South America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.8. Brazil Veterinary Pharmaceuticals Market
22.9. Brazil Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.10. Brazil Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.13. Brazil Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.14. Brazil Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

23. Middle East Veterinary Pharmaceuticals Market
23.1. Middle East Veterinary Pharmaceuticals Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. COVID-19 Impact
23.1.4. Background Information
23.1.5. Government Initiatives
23.1.6. Regulatory Bodies
23.1.7. Regulations
23.1.8. Taxes Levied
23.1.9. Corporate Tax Structure
23.1.10. Associations
23.1.11. Investments
23.1.12. Major Companies
23.2. Middle East Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.3. Middle East Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.6. Middle East Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.7. Middle East Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

24. Africa Veterinary Pharmaceuticals Market
24.1. Africa Veterinary Pharmaceuticals Market Overview
24.1.1. Region Information
24.1.2. Market Information
24.1.3. COVID-19 Impact
24.1.4. Background Information
24.1.5. Regulatory Bodies
24.1.6. Government Initiatives
24.1.7. Regulations
24.1.8. Corporate Tax Structure
24.1.9. Associations
24.1.10. Taxes Levied
24.1.11. Investments
24.1.12. Major Companies
24.2. Africa Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.3. Africa Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
24.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.5. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.6. Africa Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.7. Africa Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

25. Global Veterinary Pharmaceuticals Market Competitive Landscape
25.1. Company Profiles
25.2. Zoetis Inc.
25.2.1. Company Overview
25.2.2. Products and Services
25.2.3. Business Strategy
25.2.4. Financial Overview
25.3. BoehringerIngelheim GmbH
25.3.1. Company Overview
25.3.2. Products and Services
25.3.3. Business Strategy
25.3.4. Financial Overview
25.4. Merck & Co., Inc.
25.4.1. Company Overview
25.4.2. Products and Services
25.4.3. Business Strategy
25.4.4. Financial Overview
25.5. Elanco Animal Health Incorporated
25.5.1. Company Overview
25.5.2. Products and Services
25.5.3. Business Strategy
25.5.4. Financial Overview
25.6. Ceva Santé Animale
25.6.1. Company Overview
25.6.2. Products and Services
25.6.3. Business Strategy
25.6.4. Financial overview

26. Key Mergers and Acquisitions In The Veterinary Pharmaceuticals Market
26.1. Vibrac Acquired Assets Of Elanco Animal Health Inc.
26.2. Vetoquinol Acquired Australian Assets Of Elanco Animal Health Inc.
26.3. Elanco Animal Health Acquired Bayer Animal Health
26.4. MSD Animal Health Acquired Worldwide Rights of VECOXAN from Elanco Health
26.5. BoehringerIngelheim Acquired Global Stem cell Technology
26.6. Merck & Co. Inc. Announced The Acquisition Of Virbac’s Anti-Parasitic Portfolio
26.7. The Carlyle Group Acquired SeQuent Scientific Ltd.
26.8. Friulchem Acquired Pharmabbie
26.9. Manna Pro Acquired Promika, LLC Pet Brands
26.10. Ceva Santé Animale Acquired Assets Of IDT Biologika GmbH
26.11. Elanco Animal Health Acquired Aratana Therapeutics
26.12. Henry Schein Animal Health Merges With Vets First Choice
26.13. PHARMAQ Collaborated With VinhHoan
26.14. Animal Health Division Of Merck & Co. Collaborated With Vinovo
26.15. WageningenBioveterinary Research Collaborated With Ceva
26.16. Animalcare Group Acquired Ecuphar
26.17. Merck Animal Health Acquired Vallee S.A.
26.18. Elanco Animal Health Acquired BoehringerIngelheimVetmedica’s Vaccine Portfolio
26.19. Ceva Acquired Portfolio OfMerial Swine and Cattle Vaccines
26.20. Dechra Holdings US (A U.S Subsidiary of Dechra Pharmaceuticals PLC) Acquired Putney Inc.
26.21. ZydusCadila Acquired Zoetis
26.22. Eli Lilly and Company Acquired Novartis Animal Health

27. Market Background: Animal Medicine Market
27.1. Animal Medicine Market Characteristics
27.1.1. Market Definition
27.1.2. Segmentation Type Of Medicine
27.2. Global Animal Medicine Market, Segmentation By Type Of Medicine, 2015 - 2025, Value ($ Billion)
27.3. Global Animal Medicine Market, 2020, By Region, Value ($ Billion)
27.4. Global Animal Medicine Market, 2015 - 2025, Historic and Forecast, By Region

28.Global Veterinary Pharmaceuticals Market Opportunities and Strategies
28.1. Global Veterinary Pharmaceuticals Market In 2025 - Countries Offering Most New Opportunities
28.2. Global Veterinary Pharmaceuticals Market In 2025 - Segments Offering Most New Opportunities
28.3. Global Veterinary Pharmaceuticals Market In 2025 - Growth Strategies
28.3.1. Market Trend Based Strategies
28.3.2. Competitor Strategies

29. Veterinary Pharmaceuticals Market, Conclusions and Recommendations
29.1. Conclusions
29.2. Recommendations
29.2.1. Product
29.2.2. Place
29.2.3. Price
29.2.4. Promotion
29.2.5. People

30. Appendix
30.1. Market Data Sources
30.2. Research Methodology
30.3. Currencies
30.4. Research Inquiries
30.5. About the Publisher

31. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Boehringer Ingelheim GmbH
  • Ceva Santé Animale
  • Merck & Co., Inc.
  • Zoetis Inc.
This report describes and explains the global veterinary pharmaceuticals market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

The global veterinary pharmaceuticals market reached a value of nearly $30,862.3 million in 2020, having increased at a compound annual growth rate (CAGR) of 7.4% since 2015. The market is expected to grow from $30,862.3 million in 2020 to $63,786.5 million in 2025 at a rate of 15.6%. The market is then expected to grow at a CAGR of 14.6% from 2025 and reach $125,844.5 million in 2030.

Growth factors in the historic period include emerging markets growth, increased pet spending, increased disease prevalence, shortages of generic medicines, increased outbreak of poultry diseases. The market was restrained by shortage of veterinarians, lack of awareness, inappropriate use of medicines, cost of animal treatment, and stringent regulations.

Going forward increased penetration of pet insurance, rise in pet ownership, increase in government initiatives, and growing awareness about animal health will drive the growth in the veterinary pharmaceuticals market. Factors that could hinder the growth of the market in the future include rising threat of antibiotic resistance, consolidation of consumers and distributers, reductions in free trade, increasing influx of counterfeit drugs, and the covid-19 pandemic.

The veterinary pharmaceuticals market is segmented by type of pharmaceuticals into veterinary parasiticides, veterinary vaccines, veterinary antibiotics, and other veterinary pharmaceuticals. The veterinary parasiticides market was the largest segment of the veterinary pharmaceuticals market segmented by type of pharmaceuticals, accounting for 29.5% of the total in 2020. Going forward, the veterinary vaccines market segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by type of pharmaceuticals, at a CAGR of 16.2% during 2020-2025.

The veterinary vaccines market is sub-segmented by type of vaccine into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The live attenuated vaccines market was the largest segment of the veterinary vaccines market segmented by type of vaccine, accounting for 40.3% of the total in 2020. Going forward, the others market segment is expected to be the fastest growing segment in the veterinary vaccines market segmented by type of vaccine, at a CAGR of 18.1% during 2020-2025.

The veterinary antibiotics market is sub-segmented by type of antibiotic into tetracyclines, penicillin, macrolides, sulphanomides, aminoglycosides, and others. The others market was the largest segment of the veterinary antibiotics market segmented by type of antibiotic, accounting for 40.8% of the total in 2020. Going forward, the others market segment is expected to be the fastest growing segment in the veterinary antibiotics market segmented by type of antibiotic, at a CAGR of 18.1% during 2020-2025.

The veterinary pharmaceuticals market is also segmented by animal type into livestock and companion animal. The livestock market was the largest segment of the veterinary pharmaceuticals market segmented by animal type, accounting for 52.3% of the total in 2020. Going forward, the companion animal market segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by animal type, at a CAGR of 19.0% during 2020-2025.

The veterinary pharmaceuticals market is also segmented by route of administration into oral and others. The oral administration market was the largest segment of the veterinary pharmaceuticals market segmented by route of administration, accounting for 55.5% of the total in 2020. Going forward, the others market segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by route of administration, at a CAGR of 18.1% during 2020-2025.

The veterinary pharmaceuticals market is also segmented by end use channel into veterinary hospitals, pharmacies and drug stores and veterinary clinics. The veterinary hospitals market was the largest segment of the veterinary pharmaceuticals market segmented by end use channel, accounting for 66.9% of the total in 2020. Going forward, the veterinary clinics market segment is expected to be the fastest growing segment in the veterinary pharmaceuticals market segmented by end use channel, at a CAGR of 18.2% during 2020-2025.

North America was the largest region in the veterinary pharmaceuticals market, accounting for 44.9% of the total in 2020. It was followed by the Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the veterinary pharmaceuticals market will be Africa and South America where growth will be at CAGRs of 24.1% and 21.2% respectively during 2020-2025. These will be followed by Asia Pacific and Eastern Europe, where the markets are expected to register CAGRs of 20.3% and 20.2% respectively during 2020-2025.

Coronavirus (COVID-19) is an infectious disease that is caused by the newly discovered corona virus. COVID-19, which originated in the Wuhan province of China in December 2019, has now spread to many countries worldwide, including the USA. The World Health Organization (WHO) has declared this outbreak a pandemic.

The coronavirus pandemic has caused global economic slowdown and impacted various industries across the world, including the veterinary pharmaceuticals market. Nationwide lockdowns and restrictions on activity to contain COVID-19 are disrupting supply and demand and affecting business operations worldwide.

The covid-19 pandemic impacted the supply side of the veterinary pharmaceuticals market by impacting leading global veterinary pharmaceuticals companies, decreasing the launch in new products, higher safety measures implemented, and revocation of events, conferences and expos. The covid-19 pandemic impacted the demand side of the veterinary pharmaceuticals market by stockpiling veterinary pharmaceuticals, purchasing veterinary pharmaceuticals online, increasing pet ownership and adoption, and limiting emergency services offered by veterinarians.

The veterinary pharmaceuticals market is concentrated with a small number of large players dominating the market. The top ten competitors in the market made up to 71% of the total market in 2020. Major players in the market include Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac Group, Dechra Pharmaceuticals PLC, Phibro Animal Health Corporation, Vetoquinol S.A., and Kyoritsuseiyaku Corporation.

The top opportunities in the veterinary pharmaceuticals market segmented by type of pharmaceutical will arise in the veterinary parasiticides, which will gain $10,091.7 million of global annual sales by 2025. The top opportunities in the veterinary vaccines market segmented by type of vaccine will arise in the live attenuated vaccines segment, which will gain $3,985.2 million of global annual sales by 2025. The top opportunities in the veterinary antibiotics market segmented by type of antibiotic will arise in the others antibiotics segment, which will gain $2,393.9 million of global annual sales by 2025. The top opportunities in the veterinary pharmaceuticals market segmented by animal type will arise in the companion animal segment, which will gain $20,434.3 million of global annual sales by 2025. The top opportunities in the veterinary pharmaceuticals market segmented by route of administration will arise in the oral segment, which will gain $18,849.5 million of global annual sales by 2025. The top opportunities in the veterinary pharmaceuticals market segmented by end use channel will arise in the veterinary hospitals segment, which will gain $22,337.2 million of global annual sales by 2025.

Market-trend-based strategies for the veterinary pharmaceuticals include strategic collaboration and partnerships to drive innovation, development of chewable tablets, production of generic drugs for animal care, application of nanotechnology in veterinary medicines to tackle antibiotic resistance, oral drug solutions for the treatment of feline hypertension, use of subunit and virus-like particles (VLP)-based vaccines, use of immunotherapy, super combo parasiticides, development of vaccines, new treatment for arthritis, and use of next generation sequencing (NGS).

Player-adopted strategies in the veterinary pharmaceuticals market should include bringing innovative new therapies to improve the health of animals globally and collaborating with companies having innovative technologies for antibody development, advancing health and well-being of animals by broadening product portfolio by including more medicinal products, new product development activities through strategic collaboration agreements, value creation by acquiring companies which will help in expanding product portfolio and business operations, focusing on the development of therapeutics that could transform the way veterinarians treat a range of diseases in animals by collaborating with companies having advanced technology for research and development of new treatments.

To take advantage of these opportunities, the publisher recommends veterinary pharmaceuticals manufacturers to focus on production of easy-to-give medicines and collaborate to drive innovations as they are easy and effective, expand in emerging markets to gain market share and cater increasing demand, leverage e-commerce to maximize reach, offer competitive pricing and skimming pricing, use direct-to-consumer advertising to increase sales and market share and focus on individual customers among other strategies.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Zoetis Inc.
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll